Eventide Asset Management, LLC Galapagos Nv Transaction History

Eventide Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$76.15 - $111.94 $8.53 Million - $12.5 Million	-112,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$96.85 - $148.25 $5.91 Million - $9.04 Million	61,000 Added 119.61%	112,000 $11.1 Million
Q4 2019 Jan 29, 2020	SELL	$146.12 - $215.82 $17.8 Million - $26.3 Million	-122,000 Reduced 70.52%	51,000 $10.5 Million
Q1 2019 May 15, 2019	BUY	$89.61 - $117.78 $11.9 Million - $15.7 Million	133,000 Added 332.5%	173,000 $20.4 Million
Q1 2018 May 15, 2018	SELL	$94.51 - $120.23 $1.13 Million - $1.44 Million	-12,000 Reduced 23.08%	40,000 $3.99 Million
Q3 2017 Nov 14, 2017	BUY	$73.17 - $103.47 $3.8 Million - $5.38 Million	52,000	52,000 $5.29 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.79B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.